News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Suresh S. Ramalingam on insurance coverage challenges for Keytruda in NSCLC Patients
Photo from Suresh S. Ramalingam/X
Dec 16, 2024, 19:13

Suresh S. Ramalingam on insurance coverage challenges for Keytruda in NSCLC Patients

Suresh S. Ramalingam, Executive Director of Winship Cancer Institute of Emory University, shared a post on X:

“A patient of mine on Keytruda for NSCLC had restaging scans last week.

Before I had a chance to meet the patient to discuss results, Humana insurance sent a letter to him that he has progressed and will no longer be covered for keytruda.

Has any of you encountered this?“

cancer Humana Keytruda NSCLC OncoDaily Oncology Suresh S. Ramalingam
Special Coverage
Blog
Dec 16, 2024, 19:13
Suresh S. Ramalingam on insurance coverage challenges for Keytruda in NSCLC Patients
Insight
Dec 16, 2024, 19:10
Neoadjuvant durvalumab improves survival in early TNBC independent of pathological complete response
Insight
Dec 16, 2024, 19:07
Julie Hallet: Guidance on biomarkers gene therapy for NETs
Blog
Dec 16, 2024, 19:04
Elshad Hasanov: Vision for the future - a colorful, beautiful, and healthy brain - free of metastasis
Blog
Dec 16, 2024, 19:00
Xiuning Le: Successful EGFR Resisters Research Summit
Insight
Dec 16, 2024, 18:57
Next generation sequencing-based MSI scoring predict benefit in dMMR tumors treated with nivolumab
Blog
Dec 16, 2024, 18:53
City Cancer Challenge - A career-defining challenge proving that nothing is impossible
Blog
Dec 16, 2024, 18:48
Ben Neel on resistance and identification of synthetic lethal targets in KRAS STK11 mutant NSCLC
Blog
Dec 16, 2024, 18:45
Douglas Flora: Working alongside some of the brightest minds in healthcare
Blog
Dec 16, 2024, 18:39
Global Health Catalyst summit in Asia: Strengthening cancer care in SAARC countries
Insight
Dec 16, 2024, 18:20
Nektar Therapeutics Presented Phase 2 Results for NKTR-255 at ASH 2024
Insight
Dec 16, 2024, 18:10
Cellenkos Presented Results of Phase 1b Data for CK0804 T-Regulatory Cell Therapy in Myelofibrosis at ASH 2024